Drugwatch Investigates

Drugwatch.com
  • 0.0 (0)
  • MEDICINE
  • UPDATED WEEKLY

Drugwatch Investigates goes beyond the headlines to examine the drugs, devices and decisions that affect millions of Americans. Powered by the investigative journalists and consumer advocates of Drugwatch.com, each series combines expert voices with in-depth research to deliver the stories behind the science and the truth behind the treatments.

  1. Health on Trial: The Dangers of Roundup and the Fight for Our Legal Rights

    4 DAYS AGO

    Health on Trial: The Dangers of Roundup and the Fight for Our Legal Rights

    Discover the alarming evidence linking glyphosate, the world's most widely used herbicide, to serious health risks, including cancer. Join attorney Whitney Di Bona and Kelly Ryerson, also known as the Glyphosate Girl, as they unpack the ongoing courtroom battles, regulatory failures and urgent need for reform in our food system.  To learn more about Roundup lawsuits, visit https://www.drugwatch.com/legal/roundup-lawsuit/.  Topics covered in this episode: The scientific consensus that glyphosate is a carcinogen and its presence in rainwater, urine and even children's bodies The implications of the Supreme Court case Monsanto v. Durnell and potential corporate immunity How Bayer's legal strategies, including legislation and industry lobbying, threaten consumer rights The impact of glyphosate in food through GMO crops and pre-harvest spraying practices The differences between regenerative and organic farming, and how soil health influences nutrient density The potential for regenerative agriculture to replace harmful chemical reliance How public awareness and consumer choices can influence policy and industry practices Kelly Ryerson’s personal journey from illness to activism and her efforts to raise awareness Resources & Links: Roundup: Controversies, Health Risks and Industry Failures Stoppoison.org - mobilize against pesticide legislation Connect With Kelly Ryerson: https://www.instagram.com/glyphosategirl/ https://www.americanregeneration.org/  Note: Always consult with health and legal professionals for personalized advice. The information provided reflects current research and advocacy efforts. Nothing in this podcast constitutes legal or medical advice. The opinions of our guests do not necessarily reflect those of Drugwatch.

    55 min
  2. Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?

    5 MAY

    Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?

    In the final episode of Big Pharma Behind the Scenes, Drugwatch Investigates explores what it would take to fix the system. Hosts Terry Turner and attorney Whitney Ray Di Bona dig into the Depo-Provera meningioma warning, FDA funding, and industry influence over regulation. Plus, they ask the bigger question at the heart of the series: Can regulators keep up, or will patients always have to rely on lawsuits to get answers? You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties on Drugwatch.com here: https://www.drugwatch.com/featured/big-pharma-behind-the-scenes/

    19 min
  3. Big Pharma Behind the Scenes Ep. 5: Record Settlements — Vioxx and Major MDLs Move the Needle

    28 APR

    Big Pharma Behind the Scenes Ep. 5: Record Settlements — Vioxx and Major MDLs Move the Needle

    In this episode, we go inside some of the biggest drug and device mass torts in U.S. history. Terry Turner and Whitney Ray Di Bona explore how multidistrict litigations (MDLs) — some involving tens of thousands of lawsuits — helped expose hidden risks, uncover internal company documents and drive record settlements in cases involving Roundup, Vioxx, talc, mesh and more. You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties on Drugwatch.com here: https://www.drugwatch.com/featured/big-pharma-behind-the-scenes/

    10 min
  4. Big Pharma Behind the Scenes Ep. 4: Profits vs. Penalties — Big Government Settlements Against Big Pharma

    21 APR

    Big Pharma Behind the Scenes Ep. 4: Profits vs. Penalties — Big Government Settlements Against Big Pharma

    This episode of Big Pharma Behind the Scenes looks at the price of corporate misconduct and the billion-dollar settlements that keep repeating. Terry Turner and Whitney Ray Di Bona break down why companies like Pfizer, GSK, Johnson & Johnson and others keep showing up in enforcement actions — and whether fines, lawsuits and whistleblowers actually change behavior or just become the cost of doing business. You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties on Drugwatch.com here: https://www.drugwatch.com/featured/big-pharma-behind-the-scenes/

    18 min
  5. Big Pharma Behind the Scenes Ep. 3: Playing the Long Game — ‘Socialized Risks, Privatized Profits’

    14 APR

    Big Pharma Behind the Scenes Ep. 3: Playing the Long Game — ‘Socialized Risks, Privatized Profits’

    Drugwatch Investigates follows the money behind blockbuster drugs and toxic products to uncover a bigger pattern of socialized risk and privatized profit.  The episode looks at how slow regulation, aggressive marketing, thin approval evidence and delayed transparency can leave patients, taxpayers and insurers paying the price while companies keep selling and fighting in court. Hosts Terry Turner and Whitney Ray Di Bona interview experts to explore how advertising, orphan-drug pricing and litigation shape what the public sees — and what it doesn’t — about drug safety and value. You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties from Drugwatch.com here: https://www.drugwatch.com/featured/big-pharma-behind-the-scenes/

    17 min
  6. Big Pharma Behind the Scenes Ep. 2: Inside the Machine — Big Pharma, Profits and Lawsuits

    7 APR

    Big Pharma Behind the Scenes Ep. 2: Inside the Machine — Big Pharma, Profits and Lawsuits

    Hosts Terry Turner and Whitney Ray Di Bona unpack how companies plan for legal risk long before products reach patients — from trial design and FDA strategy to marketing, lobbying and bankruptcy maneuvers like Johnson & Johnson’s failed “Texas Two-Step” talc strategy.  The episode features investigative reporters Shannon Brownlee and Jeanne Lenzer on how drugmakers shape the evidence behind approvals. Cardiologist Dr. Peter Kowey weighs in on the profit motives that influence research and prescribing, while whistleblower advocate Louis Clark discusses the legal pressure companies use to silence critics. Former pharma insider William Soliman talks about how litigation, compliance and transparency factor into every launch.  It’s a look at how Big Pharma's profits and lawsuits are often linked from the very start. You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties from Drugwatch.com here: https://www.drugwatch.com/featured/big-pharma-behind-the-scenes/

    14 min
  7. Big Pharma Behind the Scenes Ep. 1: The Cost of Failure Measured in Injuries, Deaths and Lawsuits

    31 MAR

    Big Pharma Behind the Scenes Ep. 1: The Cost of Failure Measured in Injuries, Deaths and Lawsuits

    Drugwatch reveals how the legal system steps in when drug safety fails. Hosts Terry Turner and Whitney Ray Di Bona investigate new lawsuits over rare, permanent vision loss tied to GLP‑1 drugs like Ozempic and Wegovy. This discovery uncovers a wider trend — drugs approved on limited evidence, safety risks surfacing only after millions of prescriptions and families seeking answers in court.  Stanford law professor Nora Freeman Engstrom highlights how opioid litigation forced open the DEA's secret ARCOS database, which she calls the "Rosetta Stone" of the opioid crisis. Whistleblower advocate Louis Clark and former Merck insider William Soliman explain how Vioxx stayed on the market despite heart‑risk warnings.  Through these stories, this episode showcases how lawsuits can serve as a shadow regulator for Big Pharma, exposing hidden data, reshaping public understanding, and sometimes, finally removing dangerous drugs from the shelves. You can read more about Big Pharma Behind the Scenes: Patients, Profits and Penalties on Drugwatch.com

    25 min
  8. Beyond the Scale Bonus Episode: Health Concerns Emerge for Saxenda, Victoza

    04/09/2025

    Beyond the Scale Bonus Episode: Health Concerns Emerge for Saxenda, Victoza

    In this special bonus episode, hosts Terry Turner and Christian Simmons revisit the topic of GLP-1 drugs to dive into emerging health concerns for Saxenda and Victoza. New research has uncovered a potential link between liraglutide, the active ingredient in those drugs, and permanent vision loss. To better understand the impact of this issue, Terry and Christian once again speak with attorney Danielle Gold from Weitz & Luxenberg, who is working on vision loss cases involving GLP-1s.Learn more at ⁠Drugwatch.com⁠.

    6 min
See All (14)

About

Drugwatch Investigates goes beyond the headlines to examine the drugs, devices and decisions that affect millions of Americans. Powered by the investigative journalists and consumer advocates of Drugwatch.com, each series combines expert voices with in-depth research to deliver the stories behind the science and the truth behind the treatments.

Information

  • Creator
    Drugwatch.com
  • Years Active
    2025 - 2026
  • Episodes
    14
  • Rating
    Clean
  • Copyright
    © Drugwatch.com
  • Show Website
    Drugwatch Investigates

You Might Also Like